Suppr超能文献

苯二氮䓬类药物使用的持久性神经后遗症:一项网络调查。

Enduring neurological sequelae of benzodiazepine use: an Internet survey.

作者信息

Huff Christy, Finlayson A J Reid, Foster D E, Martin Peter R

机构信息

Benzodiazepine Information Coalition, 1042 Ft. Union Blvd., PMB 1030, Midvale, UT, 84047 USA.

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Ther Adv Psychopharmacol. 2023 Feb 6;13:20451253221145561. doi: 10.1177/20451253221145561. eCollection 2023.

Abstract

INTRODUCTION

Benzodiazepine tapering and cessation has been associated with diverse symptom constellations of varying duration. Although described in the literature decades ago, the mechanistic underpinnings of enduring symptoms that can last months or years have not yet been elucidated.

OBJECTIVE

This secondary analysis of the results from an Internet survey sought to better understand the acute and protracted withdrawal symptoms associated with benzodiazepine use and discontinuation.

METHODS

An online survey ( = 1207) was used to gather information about benzodiazepine use, including withdrawal syndrome and protracted symptoms.

RESULTS

The mean number of withdrawal symptoms reported by a respondent in this survey was 15 out of 23 symptoms. Six percent of respondents reported having all 23 listed symptoms. A cluster of least-frequently reported symptoms (whole-body trembling, hallucinations, seizures) were also the symptoms most frequently reported as lasting only days or weeks, that is, short-duration symptoms. Symptoms of nervousness/anxiety/fear, sleep disturbances, low energy, and difficulty focusing/distractedness were experienced by the majority of respondents (⩾85%) and, along with memory loss, were the symptoms of longest duration. Prolonged symptoms of anxiety and insomnia occurred in many who have discontinued benzodiazepines, including over 50% who were not originally prescribed benzodiazepines for that indication. It remains unclear if these symptoms might be caused by neuroadaptive and/or neurotoxic changes induced by benzodiazepine exposure. In this way, benzodiazepine withdrawal may have acute and long-term symptoms attributable to different underlying mechanisms, which is the case with alcohol withdrawal.

CONCLUSIONS

These findings tentatively support the notion that symptoms which are acute but transient during benzodiazepine tapering and discontinuation may be distinct in their nature and duration from the enduring symptoms experienced by many benzodiazepine users.

摘要

引言

苯二氮䓬类药物的减量和停用与持续时间各异的多种症状群相关。尽管几十年前文献中就有描述,但持续数月或数年的持久症状的机制基础尚未阐明。

目的

对一项互联网调查结果进行二次分析,旨在更好地了解与苯二氮䓬类药物使用及停用相关的急性和迁延性戒断症状。

方法

采用在线调查(n = 1207)收集有关苯二氮䓬类药物使用的信息,包括戒断综合征和迁延性症状。

结果

本调查中,受访者报告的戒断症状平均数量为23种症状中的15种。6%的受访者报告出现了所有列出的23种症状。一组最少被报告的症状(全身颤抖、幻觉、癫痫发作)也是最常被报告仅持续数天或数周的症状,即短期症状。大多数受访者(⩾85%)经历过紧张/焦虑/恐惧、睡眠障碍、精力不足以及注意力难以集中/分心症状,并且这些症状与记忆力减退一样,是持续时间最长的症状。许多停用苯二氮䓬类药物的人出现了焦虑和失眠的迁延性症状,包括超过50%最初并非因该适应症而开具苯二氮䓬类药物的人。目前尚不清楚这些症状是否可能由苯二氮䓬类药物暴露引起的神经适应性和/或神经毒性变化所致。这样一来,苯二氮䓬类药物戒断可能有急性和长期症状,其潜在机制不同,酒精戒断也是如此。

结论

这些发现初步支持了这样一种观点,即在苯二氮䓬类药物减量和停用时急性但短暂的症状,在性质和持续时间上可能与许多苯二氮䓬类药物使用者经历的持久症状不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c733/9905027/a971e8115732/10.1177_20451253221145561-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验